January 8, 2012

The U.S. Food and Drug Administration and Mylan, Inc. recently issued a voluntary product recall on several lots of their medications, Hydrocodone and Acetaminophen in 10 and 500-milligram dosages respectively. According to an FDA press release, the recall was issued after certain lots of the medications were found to exceed weight limits and could potentially contain more active ingredient than advertised.

The three affected lots of the drugs, Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg, were made by Qualitest Pharmaceuticals and were then repackaged by Mylan and it’s subsidiaries. During testing on the Drugs in December though, it was discovered that some pills found in lots 3037841, 3040859 and 3042573 exceeded weight limits, which meant the pills contained more of certain ingredients than they were supposed to. Such an error could cause a patient to ingest more of a drug’s active ingredient than intended, which could lead to a patient suffering a Drug Injury.

Anyone in possession of the affected medications should contact the product’s manufacturer to discuss any questions regarding the recall. They can be reached at 1-800-848-0462 on Monday through Friday between 8 a.m. and 5 p.m. EST.

The Drug Injury Lawyers with Ferrer Poirot Feller Daniel recognize the risks involved with taking medications that are not manufactured to certain specifications and encourage anyone who has been harmed by taking such a drug to look into their legal rights by discussing your case with an attorney.